2 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow ABS-1230: new trials by email Literature Review of ABS-1230 trials Research Report on ABS-1230
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy ABS-1230, Placebo - KCNT1-Related Epilepsy | Phase 2 | Recruiting | Actio Biosciences, Inc. | 61 | 2026-05-18 | 2026-10-15 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years ABS-1230, Placebo, Omeprazole - KCNT1-Related Epilepsy | Phase 1 | Recruiting | Actio Biosciences, Inc. | 92 | 2025-08-28 | 2026-08-07 |
Australia (1) · United States (1)